What is Heru?
Based in Miami, FL, Heru is at the forefront of vision diagnostics and augmentation technology. The company is dedicated to developing innovative solutions that address critical needs within the ophthalmology sector. By focusing on advanced diagnostics and augmentation, Heru aims to improve patient outcomes and enhance the capabilities of vision care professionals. The company's commitment to technological advancement positions it as a key player in the evolving field of medical technology.
How much funding has Heru raised?
Heru has raised a total of $32.7M across 2 funding rounds:
Angel/Seed
$2.7M
Series A
$30M
Angel/Seed (2020): $2.7M with participation from Frederic H. Moll and Maurice R. Ferre
Series A (2021): $30M led by Krillion Ventures, Frederic H. Moll, M.D., D1 Capital Partners, Maurice R. Ferre, M.D., and SoftBank Ventures Opportunity Fund
Key Investors in Heru
Krillion Ventures
Krillion Ventures is a Miami-based venture capital fund that invests in early stage technology companies focused on healthcare, financial services, and real estate. The firm seeks to partner with innovative and driven entrepreneurs who challenge the status quo and inspire others.
D1 Capital Partners
D1 Capital Partners is an investment firm with a broad investment strategy, focusing on companies across various sectors. Their involvement suggests a belief in Heru's potential for significant market impact and growth.
SoftBank Ventures Opportunity Fund
SoftBank Ventures Opportunity Fund is an investment arm that typically backs technology companies with high growth potential. Their participation indicates a strategic interest in Heru's innovative approach to vision diagnostics and augmentation.
What's next for Heru?
With the recent influx of major strategic investment, Heru is poised for accelerated growth and further innovation. This capital infusion is expected to fuel the expansion of its product development pipeline, enhance its market reach, and potentially support strategic partnerships. The company's focus on vision diagnostics and augmentation suggests a trajectory aimed at capturing a significant share of the medtech market, driven by its technological prowess and strategic financial backing.
See full Heru company page
